摘要
PAC2是垂体腺苷酸环化酶激活多肽(Pituitary adenylate cyclase activating polypeptide,PACAP)和血管活性肠肽(vasoactive intestinal peptide,VIP)的共同受体,介导多种重要生物学功能。为获得稳定特异表达VPAC2的中国仓鼠卵巢(Chinesehamsterovary,CHO)细胞,将pcDNA-VPAC2表达载体转染CHO细胞,G418筛选转染阳性克隆,PACAP38标准品诱导阳性克隆细胞的胞内cAMP生成,筛选出对PACAP38最为敏感的阳性单克隆细胞株(VPAC2-CHO),运用RT-PCR、Westernblot和免疫荧光法检测VPAC2受体表达情况,利用VPAC2受体特异激动剂通过竞争性结合试验和促进胞内第二信使cAMP生成的活性检测实验证实,VPAC2-CHO特异表达有功能的VPAC2。Scatchard作图分析显示VPAC2-CHO的VPAC2受体密度为(1.1±0.2)pmol/mg膜蛋白,PACAP38与VPAC2的解离常数Kd值为(0.55±0.10)nmol/L。特异表达VPAC2受体细胞系的构建为深入研究该受体理化性质、生物学功能以及筛选、开发VPAC2受体新型特异激动剂和拮抗剂等研究奠定了基础。
VPAC2 is a co-receptor of pituitary adenylate cyclase activating polypeptide （PACAP） and vasoactive intestinal peptide （VIP） and mediates multiple bio-functions. In order to construct the CHO line expressing VPAC2 stably, pcDNA- VPAC2 was used to transfect CHO cells. The positive clones were selected by G418 and the clone VPAC2-CHO with high sensitivity to PACAP38 was picked out by its ability to promoting the concentration of cAMP. RT-PCR, Western blot and Immunofluorescenece assay were used to identify the express of VPACS. Binding competition with VPAC2 agonist and the bioactivity of mediating the ligand to promote the concentration of cAMP showed that VPAC2 was expressed effectively in VPAC2- CHO. The results of Scatchard analysis revealed that VAPC2-CHO expressed a receptor density of （1.1 ±0.2） pmol/mg protein, respectively, with Kd values of （0.55±0. 10） nmol/L for PACAP38 used as a tracer. The construction of CHO cells expressing VPAC2 specially and functionally lays a foundation not only for the further research on the characters and functions of VPAC2 but also for the screening and characterization of novel agonists of antagonists for VPAC2.
出处
《生物工程学报》
CAS
CSCD
北大核心
2006年第6期996-1001,共6页
Chinese Journal of Biotechnology
基金
广东省自然科学基金重点项目(No.021202)
广东省科技攻关项目(No.2004A10902002)
广州市科技攻关项目(No.2006Z1-E4021)资助。~~
